Sfoglia per RIVISTA
ANTICANCER RESEARCH
Collezione AOU San Luigi di Orbassano
Items : 9
Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis. in Anticancer research / Anticancer Res. 2019 Aug;39(8):4357-4361. doi: 10.21873/anticanres.13604.
2019
AOU San Luigi di Orbassano
Palumbo C; Pecoraro A; Knipper S; Rosiello G; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;
Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study. in Anticancer research / Anticancer Res. 2019 Apr;39(4):1935-1942. doi: 10.21873/anticanres.13303.
2019
AOU San Luigi di Orbassano
DE Sanctis V; Belgioia L; Cante D; LA Porta MR; Caspiani O; Guarnaccia R; Argenone A; Muto P; Musio D; DE Felice F; Maurizi F; Bunkhelia F; Ruo Redda MG; Reali A; Valeriani M; Osti MF; Alterio D; Bacigalupo A; Russi EG;
Comparing Image-guided targeted Biopsies to Radical Prostatectomy Specimens for Accurate Characterization of the Index Tumor in Prostate Cancer. in Anticancer research / Anticancer Res. 2018 May;38(5):3043-3047. doi: 10.21873/anticanres.12560.
2018
AOU San Luigi di Orbassano
Porpiglia F; DE Luca S; Checcucci E; Garrou D; Manfredi M; Mele F; Pecoraro A; Passera R; Bollito E; Fiori C;
Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score. in Anticancer research / Anticancer Res. 2016 Sep;36(9):4833-9. doi: 10.21873/anticanres.11045.
2016
AOU San Luigi di Orbassano
Porpiglia F; DE Luca S; Passera R; Manfredi M; Mele F; Bollito E; DE Pascale A; Cossu M; Aimar R; Veltri A;
Pathological patterns of prostate biopsy in men with fluctuations of prostate cancer gene 3 score: a preliminary report. in Anticancer research / Anticancer Res. 2015 Apr;35(4):2417-22.
2015
AOU San Luigi di Orbassano
De Luca S; Passera R; Cappia S; Bollito E; Randone DF; Porpiglia F;
Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy. in Anticancer research / Anticancer Res. 2014 Dec;34(12):7159-65.
2014
AOU San Luigi di Orbassano
De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F;
Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients. in Anticancer research / Anticancer Res. 2008 Sep-Oct;28(5B):3055-60.
2008
AOU San Luigi di Orbassano
Bitossi R; Sculli CM; Tampellini M; Alabiso I; Brizzi MP; Ferrero A; Ottone A; Bellini E; Gorzegno G; Berruti A; Dogliotti L;
Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients. in Anticancer research / Anticancer Res. 2005 Nov-Dec;25(6C):4475-9.
2005
AOU San Luigi di Orbassano
Berruti A; Mosca A; Bitossi R; Gorzegno G; Guercio S; Poggio M; Tampellini M; Porpiglia F; Ostellino O; Scarpa RM; Dogliotti L;
Biochemical picture of bone metabolism in breast cancer patients with bone metastases. in Anticancer research / Anticancer Res. 1995 Nov-Dec;15(6B):2871-5.
1995
AOU San Luigi di Orbassano
Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A;